Clinical Trial Update: Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial investigating liraglutide as an additional treatment to insulin in autoimmune-type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diabetes
• Type 1 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Type 1 Diabetes Mellitus, Autoimmune Diabetes | Phase 4 | Status: UNKNOWN